Philip P. Boudreau - Jun 16, 2023 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Role
VICE PRESIDENT
Signature
/s/ Philip P. Boudreau by Jessica H. Paik, Attorney-in-Fact
Stock symbol
ABT
Transactions as of
Jun 16, 2023
Transactions value $
-$848,000
Form type
4
Date filed
6/20/2023, 06:55 PM
Previous filing
Mar 2, 2023
Next filing
Sep 6, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABT Common shares without par value Sale -$848K -8K -34.12% $106.00 15.4K Jun 16, 2023 Direct F1
holding ABT Common shares without par value 347 Jun 16, 2023 Profit Sharing Trust F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sale transaction was made pursuant to a Rule 10b5-1(c) plan adopted on February 24, 2023.
F2 Balance in the Abbott Laboratories Stock Retirement Trust as of June 16, 2023.